Increased activity of membrane glycoprotein PC-1 in the fibroblasts from non-insulin-dependent diabetes mellitus patients with insulin resistance

Citation
S. Teno et al., Increased activity of membrane glycoprotein PC-1 in the fibroblasts from non-insulin-dependent diabetes mellitus patients with insulin resistance, DIABET RE C, 45(1), 1999, pp. 25-30
Citations number
19
Categorie Soggetti
Endocrynology, Metabolism & Nutrition
Journal title
DIABETES RESEARCH AND CLINICAL PRACTICE
ISSN journal
01688227 → ACNP
Volume
45
Issue
1
Year of publication
1999
Pages
25 - 30
Database
ISI
SICI code
0168-8227(199908)45:1<25:IAOMGP>2.0.ZU;2-E
Abstract
Although most of patients with non-insulin-dependent diabetes mellitus (NID DM) have insulin resistance, it is unknown whether a molecule might interfe re with insulin action. Membrane glycoprotein PC-1 (plasma cell antigen-1), which inhibits insulin receptor tyrosine kinase activity, was isolated fro m fibroblasts of NIDDM patients. Because PC-I content in skeletal muscle an d adipose tissue correlated with whole body insulin sensitivity, PC-I might play a role in insulin resistance. In order to know whether PC-1 activity of fibroblasts is also elevated in Japanese NIDDM patients, and whether PC- 1 activity correlates with the parameters of insulin resistance in vivo or not, we measured PC-1 activity of cultured fibroblasts from 17 patients wit h NIDDM and seven healthy controls. PC-1 activity of the NIDDM patients was 85.2 +/- 33.1 nmol/mg per min (mean +/- S.D.), and was higher than that of healthy controls (42.6 +/- 12.7 nmol/mg per min, P = 0.0002). Insulin sens itivity was measured in 11 of 17 NIDDM patients by the artificial pancreas. PC-1 activity of the patients with insulin resistance (glucose infusion ra te < 3.0 mg/kg per min, n = 7) was elevated to 99.9 +/- 31.9 nmol/mg per mi n, while that of the other patients (n = 4) was 55.3 +/- 7.5 nmol/mg per mi n (P = 0.003). In conclusion, glycoprotein PC-1 activity of dermal fibrobla sts is correlated with insulin resistance in patients with NIDDM. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.